Icon PLC

ICLR

Company Profile

  • Business description

    Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

  • Contact

    South County Business Park
    Leopardstown
    DublinD18 X5R3
    IRL

    T: +353 12912000

    https://www.iconplc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    39,900

Icon PLC News & Analysis

stocks

Finding bargains in global small to mid-cap stocks

Medical scopes, orthodontics, pet care and groceries have proved fertile ground for Bell Asset Management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,231.102.600.03%
CAC 407,743.9334.120.44%
DAX 4024,046.21106.66-0.44%
Dow JONES (US)45,587.55169.480.37%
FTSE 1009,255.5010.30-0.11%
HKSE25,201.76323.16-1.27%
NASDAQ21,576.1731.900.15%
Nikkei 22542,520.27125.870.30%
NZX 50 Index12,861.8496.14-0.74%
S&P 5006,481.4815.540.24%
S&P/ASX 2008,960.500.70-0.01%
SSE Composite Index3,800.3568.03-1.76%

Market Movers